Figure 3 from Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies

<p>Histologic expression of basal markers in breast tumor samples. <b>A,</b> Representative sections of tB- and nB-TNBC samples stained with the indicated BaC markers. Scale bar, 50 μm. <b>B,</b> Bar plots representing the percentage of cells expressing each marker in tB- and nB-TNBCs. *, <i>P</i> < 0.05 based on unpaired <i>t</i> test (Holm–Sidak method); ns, not significant. <b>C, </b>Left, representative images showing TAGL staining in tB- and nB-TNBC tumors. Scale bar, 200 and 50 μm in the insets.</p>